公开(公告)号：EP1836203A2

公开(公告)日：2007-09-26

申请号：EP06718423.4

申请日：2006-01-13

申请人： NEUROGEN CORPORATION

发明人： CALDWELL, Timothy M. ,  CHENARD, Bertrand ,  HODGETTS, Kevin

IPC分类号： C07D471/02 ,  C07D215/38 ,  C07D215/44 ,  C07D401/00 ,  C07D403/00 ,  C07D409/00 ,  C07D239/02 ,  C07D471/00 ,  C07D487/00 ,  C07D491/00 ,  C07D495/00 ,  C07D497/00 ,  A01N43/58 ,  A01N43/60 ,  A01N43/54 ,  A01N43/42 ,  A61K31/50 ,  A61K31/45 ,  A61K31/501 ,  A61K31/505 ,  A61K31/47

CPC分类号： C07D471/04 ,  C07D417/14

摘要： Heteroaryl substituted quinolin-4-ylamine analogues of Formula (I) are provided. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.